Jingxin Mo
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- Lee Yong LimZhixiang YuanWei ZhaoColin L. RastonQinghua LiPaul K. EggersBinbin LiHonglian Dai
- Journals
- Frontiers in Pharmacology (9 papers)Scientific Reports (2 papers)Frontiers in Bioengineering and Biotechnology (2 papers)Drug Delivery (2 papers)Analytical and Bioanalytical Chemistry (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Jingxin Mo
30 papers receiving 896 citations
Peers
Comparison fields: 5 of 99
- Biomaterials 250
- Molecular Medicine 52
- Pharmaceutical Science 62
- Oncology 193
- Cancer Research 94
Countries citing papers authored by Jingxin Mo
This map shows the geographic impact of Jingxin Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxin Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxin Mo more than expected).
Fields of papers citing papers by Jingxin Mo
This network shows the impact of papers produced by Jingxin Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxin Mo. The network helps show where Jingxin Mo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingxin Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2022 | 22 | |
| 6 | 2020 | 33 | |
| 7 | 2019 | 48 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 24 | |
| 10 | 2017 | 82 | |
| 11 | 2017 | 49 | |
| 12 | 2017 | 42 | |
| 13 | 2016 | 53 | |
| 14 | 2016 | 62 | |
| 15 | 2016 | 49 | |
| 16 | 2016 | 67 | |
| 17 | 2015 | 34 | |
| 18 | 2015 | 32 | |
| 19 | 2014 | 17 | |
| 20 | 2014 | 16 |
About Jingxin Mo
Jingxin Mo is a scholar working on Biomaterials, Molecular Medicine, Oncology, Biomedical Engineering and Clinical Biochemistry, having authored 31 papers that have together received 903 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Graphene and Nanomaterials Applications (8 papers), Cancer Cells and Metastasis (6 papers), Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers), 3D Printing in Biomedical Research (3 papers), Graphene research and applications (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Biomaterials (250 citations), Molecular Medicine (52 citations), Pharmaceutical Science (62 citations), Oncology (193 citations) and Cancer Research (94 citations). Jingxin Mo has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Lee Yong Lim, Zhixiang Yuan, Wei Zhao, Colin L. Raston, Qinghua Li, Paul K. Eggers, Binbin Li, Honglian Dai, Xiaojia Huang and Bing Lu. Their work appears in journals such as Frontiers in Pharmacology, Scientific Reports, Frontiers in Bioengineering and Biotechnology, Drug Delivery and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.